Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cost of Goods | 930 | 1,302 | 1,682 | 2,197 | 284 |
| Gross Profit | -930 | -1,302 | -1,682 | -2,197 | -284 |
| Operating Expenses | 3,731 | 4,425 | 3,876 | 3,334 | 2,547 |
| Operating Income | -4,661 | -5,727 | -5,559 | -5,530 | -2,831 |
| Interest Expense | 230 | 272 | 316 | 0 | 2,595 |
| Other Income | -4,877 | 373 | -822 | 1,544 | 318 |
| Pre-tax Income | -9,767 | -5,625 | -6,696 | -3,987 | -5,108 |
| Net Income Continuous | -9,767 | -5,625 | -6,696 | -3,987 | -5,108 |
| Minority Interests | 7 | 6 | 6 | 8 | 9 |
| Net Income | $-9,760 | $-5,619 | $-6,691 | $-3,979 | $-5,099 |
| EPS Basic Total Ops | -1.71 | -1.81 | -2.40 | -2.00 | -2.80 |
| EPS Basic Continuous Ops | -1.71 | -1.81 | -2.40 | -2.00 | -2.80 |
| EPS Diluted Total Ops | -1.71 | -1.81 | -2.40 | -2.00 | -2.80 |
| EPS Diluted Continuous Ops | -1.71 | -1.81 | -2.40 | -2.00 | -2.80 |
| EBITDA(a) | $-8,949 | $-4,715 | $-5,735 | $-3,423 | $-2,387 |